Search
EyePoint Pharmaceuticals Inc
EYPTAdd to Watchlist
0.380USD
+0.003+0.80%
Close 10-29 16:00（ET）
32.76MMarket Cap
LossP/E TTM
EyePoint Pharmaceuticals Inc (EYPT) Stock Price Target & Forecast
Analyst Rating
Based on 13 analysts giving stock ratings to EyePoint Pharmaceuticals Inc in the past month.
Hold
4 Strong Buy
3 Buy
6 Hold
0 Sell
0 Strong Sell
Target Price
5.188USD+1274.54%
EYPT Analyst Recommendation Trends
In the current month, EYPT has received 3 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. EYPT average Analyst price target in the last month is 5.188.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
4
4
5
4
4
4
4
4
3
3
9
8
8
8
8
8
6
6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13
13
14
12
12
12
12
12
EYPT Analyst Rating for Peer Comparison
Updated: Oct 29, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Biogen Inc
BIIB
8
16
12
1
0
37
Amgen Inc
AMGN
4
9
19
3
1
36
Vertex Pharmaceuticals Inc
VRTX
10
17
5
0
1
33
Eli Lilly and Co
LLY
10
19
3
1
0
33
Alnylam Pharmaceuticals Inc
ALNY
7
17
8
0
0
32
AbbVie Inc
ABBV
8
18
6
0
0
32
Gilead Sciences Inc
GILD
7
18
6
0
0
31
Merck & Co Inc
MRK
7
16
8
0
0
31
Neurocrine Biosciences Inc
NBIX
13
14
4
0
0
31
Bristol-Myers Squibb Co
BMY
5
6
18
1
0
30
Financial Forecasting
Based on analysts' estimates, EYPT EPS is projected to reach -0.931 in FY2026Q3, following reported EPS of -1.092 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.75
-0.81
-0.95
-0.93
-0.70
Actual
-0.81
-0.99
-1.09
--
--
Surprise
-8.75%
-22.11%
-14.73%
--
--
FAQs
What is EyePoint Pharmaceuticals Inc's expected revenue for the next quarter?
EyePoint Pharmaceuticals Inc's expected revenue is 223.08K.
What is EyePoint Pharmaceuticals Inc's price target?
Analysts forecast that EyePoint Pharmaceuticals Inc's price target is USD 5.19, with the highest forecast at USD 20.00 and the lowest forecast at USD 0.50.
How have EyePoint Pharmaceuticals IncEYPT's recent earnings per share performed?
The market expectation was USD -1.09, while EyePoint Pharmaceuticals IncEYPT's earnings per share (EPS) for the previous quarter was USD -0.99. EPS for the next quarter is expected at USD -0.93.
What is the analyst rating for EyePoint Pharmaceuticals Inc?
Based on the ratings of EyePoint Pharmaceuticals Inc's stock from 13 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.